SpaceX Scrubs Starship Test Flight Schedules Retry for Friday as IPO Plans Advance From Fragile Promise to Identity The Decade That Reshaped American Soccers Financial Landscape Tropic Launches Intelligence Hub and Integrates Procurement Data with ChatGPT Puig Shares Slide as Este Lauder Collaboration Discussions End European Markets Edge Higher Spencer Pratts Online Campaign Strategy A Case Study in Digital Political Marketing and Its Potential Market Implications Inflation Projected to Reach 6 in Second Quarter Leading Forecasters Warn HG Q1 2026 Earnings EPS Beats Estimates by 614 Shares Edge Higher SLDP Q1 2026 Earnings Solid Power Beats EPS Estimates by a Wide Margin PreRevenue Status Maintained CVI Q1 2026 Earnings Deep Losses and Wide Miss Signal Challenging Refining Environment Red Violet Inc RDVT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response CLBK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Rate Environment ACIW Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher TaskUs Inc TASK Rallies 264 as Buyers Defend Key Support Level Golden Entertainment GDEN Holds Steady at 2855 as Support and Resistance Levels Come into Focus Japan Smaller Capitalization Fund JOF Edges Lower Amid Modest Pullback Nuveen Pennsylvania Quality Municipal Income Fund NQP Shows Minimal Movement Amid Steady Trading Starfighters Space Inc FJET Maintains Uptrend Resistance at 701 in Focus Great Britain Retail Sales Fall 13 in April as Fuel Purchases See Sharpest Drop Since Pandemic Similarweb SMWB Q1 2026 Earnings EPS Turns Positive but Misses Estimates Stock Surges 926 CII Holds Steady at 2479 as Price Action Remains RangeBound Inhibikase Therapeutics IKT Holds Steady at 170 as Support and Resistance Levels Tighten Replimune Group REPL Rises 28 Approaching Resistance at 497 Immersion Corporation IMMR Edges Higher Stock Gains 223 as It Tests Key Levels Rezolve AI Warrants RZLVW Edge Higher Navigating Support and Resistance Levels Good Times Restaurants Inc GTIM Slips 23 as Resistance Holds Near 134 XBiotech Inc XBIT Edges Higher Approaching Key Resistance at 256 Seres Therapeutics MCRB Declines 593 as Selling Pressure Intensifies